Madrigal Pharmaceuticals
MDGL
MDGL
151 hedge funds and large institutions have $1.09B invested in Madrigal Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 60 increasing their positions, 37 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
8.49% less ownership
Funds ownership: 76.17% → 67.69% (-8.5%)
23% less capital invested
Capital invested by funds: $1.43B → $1.09B (-$334M)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Holders
151
Holding in Top 10
2
Calls
$5.62M
Puts
$4.91M
Top Buyers
| 1 | +$23.6M | |
| 2 | +$15.9M | |
| 3 | +$9.56M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$9.29M |
| 5 |
LC
L1 Capital
Melbourne VIC 3000,
Australia
|
+$5.09M |
Top Sellers
| 1 | -$139M | |
| 2 | -$16.5M | |
| 3 | -$10.9M | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$10.1M |
| 5 |
PHS
PFM Health Sciences
San Francisco,
California
|
-$9.65M |